<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04140422</url>
  </required_header>
  <id_info>
    <org_study_id>ETK 366/19</org_study_id>
    <nct_id>NCT04140422</nct_id>
  </id_info>
  <brief_title>Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea</brief_title>
  <acronym>EDEMAS</acronym>
  <official_title>Efficacy of Hyperosmolar Eye Drops in Diurnal Corneal Edema in Fuchs Endothelial Dystrophy: a Double Blind Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Eye Hospital, Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Eye Hospital, Freiburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy of hyperosmolar eye drops on early morning edema of the
      cornea in patients with Fuchs' endothelial corneal dystrophy (FECD). Each participant will
      receive hyperosmolar eye drops in one eye and lubricating eye drops in the fellow eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hyperosmolar eye drops are lubricating eye drops with 5% of sodium chloride. Hyperosmolar eye
      drops are thought to temporarily deswell the cornea.

      During morning hours, patients with Fuchs' endothelial corneal dystrophy (FECD) typically
      report poor vision and disturbing glare because of corneal edema. To improve vision in
      advanced stages of the disease, corneal endothelial transplantation has become the treatment
      of choice. Many patients with Fuchs' endothelial corneal dystrophy (FECD) use hyperosmolar
      eye drops before transplantation. At present, it is unclear, how much hyperosmolar eye drops
      help reducing corneal edema in Fuchs' endothelial corneal dystrophy (FECD). Based on our
      previous work that determined the amount of additional corneal edema in the morning in
      patients with Fuchs' endothelial corneal dystrophy (FECD), the investigators will assess if
      hyperosmolar eye drops speed up the deswelling process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 24, 2019</start_date>
  <completion_date type="Actual">June 25, 2020</completion_date>
  <primary_completion_date type="Actual">June 25, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study uses both eyes of the participant to allow inter- and intraindividual comparisons. One eye will be randomized to be treated with hyperosmolar eye drops, the fellow eye will be treated with lubricating eye drops.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>The allocation is done randomly by the hospitals pharmacy. By using identical containers for the hyperosmolar eye drops and the lubricating eye drops participants and medical staff are not able to distinguish both substances.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in corneal thickness</measure>
    <time_frame>Between eye opening in the morning (7 am; Hour 0) and 1 hour later (Hour 1)</time_frame>
    <description>Tomography to determine the thickness of the cornea</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in corneal thickness over time</measure>
    <time_frame>Over the first 4 hours after eye opening (Hour 0 to Hour 4) and at presumed steady-state in the afternoon (Hour 9)</time_frame>
    <description>Tomography to determine the thickness of the cornea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in corneal backscatter over time</measure>
    <time_frame>Over the first 4 hours after eye opening (Hour 0 to Hour 4) and at presumed steady-state in the afternoon (Hour 9)</time_frame>
    <description>Tomography to determine corneal backscatter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in forward scatter over time</measure>
    <time_frame>Over the first 4 hours after eye opening (Hour 0 to Hour 4) and at presumed steady-state in the afternoon (Hour 9)</time_frame>
    <description>Stray light meter measurement to determine the forward scatter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in visual acuity over time</measure>
    <time_frame>Over the first 4 hours after eye opening (Hour 0 to Hour 4) and at presumed steady-state in the afternoon (Hour 9)</time_frame>
    <description>Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity charts to determine visual acuity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in subjective visual acuity</measure>
    <time_frame>Over the first 4 hours after eye opening (Hour 0 to Hour 4) and at presumed steady-state in the afternoon (Hour 9)</time_frame>
    <description>Question on presumed change of vision</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Fuchs' Endothelial Dystrophy</condition>
  <arm_group>
    <arm_group_label>Hyperosmolar Eye Drops</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5% sodium chloride eye drops with 0,15% hyaluronic acid; one drop after waking up and one drop 30 min later on study day; investigator administered</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lubricating Eye Drops</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Lubricating eye drops with 0,15% hyaluronic acid; one drop after waking up and one drop 30 min later on study day; investigator administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyperosmolar eye drops</intervention_name>
    <description>Application of one preservative-free hyperosmolar eye drop, when waking up and one eye drop 30 min later to one eye by the investigators</description>
    <arm_group_label>Hyperosmolar Eye Drops</arm_group_label>
    <other_name>ODM 5 (CE0459)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Application of one preservative-free lubricating eye drop, when waking up and one eye drop 30 min later to the fellow eye by the investigators</description>
    <arm_group_label>Lubricating Eye Drops</arm_group_label>
    <other_name>Placebo (for hyperosmolar eye drops)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of advanced Fuchs' endothelial corneal dystrophy (FECD)

          -  Indication for corneal endothelial transplantation (Descemet Membrane Endothelial
             Keratoplasty - DMEK)

          -  Must be able to speak and understand German or English.

        Exclusion Criteria:

          -  Other corneal diseases (i.e. epithelial defects except for bullae caused by Fuchs'
             endothelial corneal dystrophy (FECD), corneal scars, postoperative / bullous
             keratopathy, corneal degenerations / dystrophies, corneal inflammation / infection)

          -  Regular use of drugs potentially affecting the cornea (i.e. amiodarone, chloroquine,
             triptan, isotretinoin, constant use of antihistamines, use of contact lenses in past
             four weeks, anesthetic eye drops, corticosteroid eye drops, antibiotic eye drops in
             past four weeks, glaucoma drops, hyperosmolar eye drops within the past 24 hours)

          -  Systemic diseases that affect the cornea (e.g. connective tissue disease, complicated
             diabetes mellitus)

          -  Lack of fixation during corneal tomography
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katrin Wacker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Freiburg, Eye Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center - University of Freiburg, Eye Hospital</name>
      <address>
        <city>Freiburg</city>
        <state>Baden-Wuerttemberg</state>
        <zip>79106</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Fritz M, Grewing V, Maier P, Lapp T, BÃ¶hringer D, Reinhard T, Wacker K. Diurnal Variation in Corneal Edema in Fuchs Endothelial Corneal Dystrophy. Am J Ophthalmol. 2019 Nov;207:351-355. doi: 10.1016/j.ajo.2019.08.002. Epub 2019 Aug 12.</citation>
    <PMID>31415734</PMID>
  </reference>
  <reference>
    <citation>Wacker K, Baratz KH, Bourne WM, Patel SV. Patient-Reported Visual Disability in Fuchs' Endothelial Corneal Dystrophy Measured by the Visual Function and Corneal Health Status Instrument. Ophthalmology. 2018 Dec;125(12):1854-1861. doi: 10.1016/j.ophtha.2018.06.018. Epub 2018 Aug 10.</citation>
    <PMID>30104038</PMID>
  </reference>
  <reference>
    <citation>Wilson SE, Bourne WM. Fuchs' dystrophy. Cornea. 1988;7(1):2-18. Review.</citation>
    <PMID>3280235</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Eye Hospital, Freiburg</investigator_affiliation>
    <investigator_full_name>Katrin Wacker, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Corneal edema</keyword>
  <keyword>Descemet membrane endothelial keratoplasty (DMEK)</keyword>
  <keyword>Hyperosmolar eye drops</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fuchs' Endothelial Dystrophy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

